Metabolism of Mitomycin C by DT-Diaphorase: Role in Mitomycin C-induced DNA Damage and Cytotoxicity in Human Colon Carcinoma Cells

Cancer Research

Volumn 50, Issue 23, 1990, Pages 7483-7489

  Siegel, David ^a   Ross, David ^a   Gibson, Neil W ^b   Preusch, Peter C ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF AKRON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICOUMAROL; DIHYDROLIPOAMIDE DEHYDROGENASE; MITOMYCIN C;

ARTICLE; COLON CARCINOMA; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; COLONY-FORMING UNITS ASSAY; DICUMAROL; DNA DAMAGE; HUMAN; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MITOMYCIN; MITOMYCINS; NAD; NAD(P)H DEHYDROGENASE (QUINONE); QUINONE REDUCTASES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025688249     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Iyer, V. N., and Szybalski, W. A molecular mechanism of mitomycin action. Link of complementary DNA strands. Proc. Natl. Acad. Sci. USA, 50: 355–362, 1963.
2. Schwartz, H. S., Sodergren, J. E., and Philips, F. S. Mitomycin C: chemical and biological studies on alkylation. Science (Washington DC), 42: 1181–1183, 1963.
3. Iyer, V. N., and Szybalski, W. Mitomycins and porf�romycin: chemical mechanism of activation and crosslinking of DNA. Science (Washington DC), 45: 55–58, 1964.
4. Lin, A. J., Cosby, L. A., and Sartorelli, A. C. Potential bioreductive alkylating agents, n: A. C. Sartorelli (ed.). Cancer Chemotherapy, pp. 71–86. Washington D. C.: American Chemical Society, 1976.
5. Powis, G. Metabolism and reactions of quinoid anticancer agents. Pharmacol. Ther., 35: 57–162, 1987.
6. Pan, S. S., Iracki, T., and Bachur, N. R. DNA alkylation by enzyme activated mitomycin C. Mol. Pharmacol., 29: 622–628, 1986.
7. Egbertson M., and Danishefsky S. J. Modeling of the electrophilic activation of mitomycins: chemical evidence for the intermediacy of a mitosene semi-quinone as the active electrophile. J. Am. Chem. Soc., 09: 2204–2205, 1987.
8. Tomasz, M., Lipman, R., Verdine, G. L., and Nakanishi, K. J. Am. Chem. Soc., 707: 6120–6121, 1985.
9. Moore, H. W., and Czemiak, R. Naturally occurring qui�ones as potential bioreductive alkylating agents. Med. Res. Rev., 1: 249–280, 1981.
10. Sinha, B. K., and Chignell, C. F. Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA. Chem. Biol. Interact., 28: 301–308, 1979.
11. Komiyama, T., Kikuchi, T., and Sugiura, Y. Generation of hydroxyl radical by anticancer quinone drugs carbazilquinone, mitomycin C., aclacinomycin A and Adriamycin in the presence of NADPH cytochrome P450 reductase. Biochem. Pharmacol., 37: 3651–3656, 1982.
12. Doroshow, J. H. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich cancer cells by antitumor qui�ones. Proc. Natl. Acad. Sci. USA, 3: 4514–4518 1986.
13. Dusre, L., Covey, J. M., Collins, C., and Sinha, B. K. DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells. Chem. Biol. Interact., 77: 63–78, 1989.
14. Butler, J., Hoey, B. M., and Swallow, A. J. Reactions of the semiquinone free radicals of antitumour agents with oxygen and iron complexes. FEBS Utt., 82: 95–98, 1985.
15. Peterson, D. W., and Fisher, J. Autocatalytic quinone methide formation from mitomycin C. Biochemistry, 25: 4077–4084, 1986.
16. Schwartz, H. S. Pharmacology of mitomycin C: III. n-vitro metabolism by rat liver. J. Pharmacol. Exp. Ther., 36: 250–258, 1962.
17. Tomasz, M., and Lipman, R. Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry, 20: 5056–5061, 1981.
18. Kennedy, K. A., and Sartorelli, A. C., Metabolic activation of mitomycin C by isolated liver nuclei and microsomes. Fed. Proc., 38: 443, 1979.
19. Kennedy, K. A., Sligar, S. G., Polomski, L., and Sartorelli, A. C. Metabolic activation of mitomycin C by liver microsomes and nuclei. Biochem. Pharmacol., 37: 2011–2016, 1982.
20. Pan, S. S., Andrews, P. A., Glover, C. J., and Bachur, N. R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH cytochrome P450 reductase and xanthine oxidase. J. Biol. Chem., 259: 959–966, 1984.
21. Tomasz, M., and Lipman, R. Alkylation reactions of mitomycin C at acid pH. J. Am. Chem. Soc., 707: 6063–6067, 1979.
22. Tomasz, M., Lipman. R., Verdine, G. L., and Nakanishi, K. Reassignment of the guanine binding mode of reduced mitomycin C. Biochemistry, 25: 4337–4344, 1986.
23. Zein, N., and Kohn, H. Covalent binding of mitomycin C to nucleosides under reductive conditions. J. Am. Chem. Soc., 09: 1576–1577, 1987.
24. Hahimoto, Y., Shudo, K., and Okamoto, T. Modif�cation of deoxyribonucleic acid with reductively activated mitomycin C. Structures of modif�ed nucleotides. Chem. Pharm. Bull. (Tokyo), 37: 861–869, 1983.
25. Tomasz, M., Lipman, R., Chowdary, D., Pawlak, J., Verdine, G. L., and Nakanishi, K. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (Washington DC), 235: 1204–1208, 1987.
26. Kennedy, K. A., McGurl, J. D., Leondaridis, L., and Alabaster, O. pH-dependence of mitomycin C-induced cross linking activity in EMT6 tumor cells. Cancer Res., 45: 3541–3547, 1985.
27. Emster, L. DT-diaphorase. Methods Enzymol., 8: 309–317, 1967.
28. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res., 45: 213–216, 1985.
29. Schlager, J. J., and Powis, G. Mitomycin C is not metabolized but is an inhibitor of human kidney NAD(P)H: (quinone acceptor) oxidoreductase. Cancer Chemother. Pharmacol., 22: 126–130, 1988.
30. Pritsos, C. A., Pardini, L. L., Elliott, A. J., and Pardini, R. S. Relationship between the antioxidant enzyme DT-diaphorase and tumor response to mitomycin C treatment, n: M. G. Simic, K. A. Taylor, J. F. Ward, and C. von Sonntag (eds.). Oxygen Radicals in Biology and Medicine, pp. 713–716. New York: Plenum Press, 1987.
31. Begleiter, A., Robotham, E., Lacey, G., and Leith, M. K. Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett., 45: 173–176, 1989.
32. Marshall, R. S., Paterson, M. C., and Rauth, A. M. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br. J. Cancer, 59: 341–346, 1989.
33. Dulhanty, A. M., Li, M., and Whitmore, G. F. Isolation of Chinese hamster ovary cells deficient in excision repair and mitomycin C bioactivation. Cancer Res., 49: 117–122, 1989.
34. Workman, P., Walton, M. I., Powis, G., and Schlager, J. J. DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs. Br. J. Cancer, 60: 800–802, 1989.
35. Marshall, R., Rauth, A. M., and Paterson, M. Reply to the letter from Workman et ai. Br. J. Cancer, 60: 803, 1989.
36. Gibson, N. W. Characterization of DNA damage and cytotoxicity induced in two human colon carcinoma cell lines by cyclodisone. Cancer Res., 49: 154–157, 1989.
37. Kohn, K. W., Ewig, R. A. G., Erickson, L. C., and Zwelling, L. A. Measurement of strand breaks and cross links by alkaline elution. 7n: E. C. Friedberg and P. C. Hanowalt (eds.), DNA Repair: A Laboratory Manual of Research Procedures, pp. 379–381. New York: Marcel Dekker, 1981.
38. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 793: 265–275, 1951.
39. Benson, A. M., Hunkier, M. J., and Talalay, P. Increase of NAD(P)H: quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA, 77: 5216–5220, 1980.
40. Sharkis D. H., and Swenson R. P. Purification by cibacron blue F3GA dye affinity chromatography and comparison of NAD(P)H: quinone reductase (E. C. 1.6.99.2) from rat liver cytosol and microsomes. Biochem. Biophys. Res. Commun., 767: 434–441, 1989.
41. Siegel, D., Gibson, N. W., Prusch, P., and Ross, D. Metabolism of diaziquone by NAD(P)H: (quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50: 7293–7300, 1990.
42. Hojberg, B., Blomberg, K., Stenberg, S., and Lind, C. Biospecific adsorption of hepatic DT-diaphorase on immobilized dicoumarol 1. Purification of cytosolic DT-diaphorase from control and 3-methylcholanthrene treated rats. Arch. Biochem. Biophys., 207: 205–216, 1981.
43. Jones, D. P. Determination of pyridine nucleotides in cell extracts by high performance liquid chromatography. J. Chromatogr., 225: 446–449, 1981.
44. Brown, K., and Fridovitch, I. DNA strand scission by enzymatically generated oxygen radicals. Arch. Biochem. Biophys., 206: 414–419, 1981.
45. Danishefsky, S., and Ciufolini, M. Leucomitomycins. J. Am. Chem. Soc., 06: 6424–6425, 1984.
46. Hoey, B. M., Butler, J., and Swallow, A. J. Reductive activation of mitomycin C. Biochemistry, 27: 2608–2614, 1988.
47. Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G., and Sartorelli, A. C. Role of NADPH: cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res., 44: 5638–5643, 1984.
48. Rockwell, S., Keyes, S. R., and Sartorelli, A. C. Modulation of the cytotoxicity of mitomycin C by dicoumarol in vitro. Cancer Res., 48: 5471–5474, 1988.
49. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Cancer Res., 49: 3310–3313, 1989.
50. Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors. A review. Cancer Res., 49: 6449–6465, 1989.
51. Kennedy, K. A., Rockwell, S., and Sartorelli, A. C. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res., 40: 2356–2360, 1980.